AZ-4175

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameAZ-4175
Drug Alias Nameimmunomodulators (AstraZeneca)AZ-5107AZ-977AZ-982AZ-4175 +[6] 
ClassificationSmall molecules
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsRejection of organ transplantationArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca Plc
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A